1. Home
  2. SLNO vs SWI Comparison

SLNO vs SWI Comparison

Compare SLNO & SWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • SWI
  • Stock Information
  • Founded
  • SLNO 1999
  • SWI 1999
  • Country
  • SLNO United States
  • SWI United States
  • Employees
  • SLNO N/A
  • SWI N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SWI Computer Software: Prepackaged Software
  • Sector
  • SLNO Health Care
  • SWI Technology
  • Exchange
  • SLNO Nasdaq
  • SWI Nasdaq
  • Market Cap
  • SLNO 2.3B
  • SWI 2.4B
  • IPO Year
  • SLNO 2014
  • SWI 2009
  • Fundamental
  • Price
  • SLNO $71.99
  • SWI $18.43
  • Analyst Decision
  • SLNO Strong Buy
  • SWI Hold
  • Analyst Count
  • SLNO 8
  • SWI 5
  • Target Price
  • SLNO $92.00
  • SWI $18.30
  • AVG Volume (30 Days)
  • SLNO 1.8M
  • SWI 1.5M
  • Earning Date
  • SLNO 05-08-2025
  • SWI 05-01-2025
  • Dividend Yield
  • SLNO N/A
  • SWI 5.43%
  • EPS Growth
  • SLNO N/A
  • SWI N/A
  • EPS
  • SLNO N/A
  • SWI 0.64
  • Revenue
  • SLNO N/A
  • SWI $796,895,000.00
  • Revenue This Year
  • SLNO N/A
  • SWI $3.55
  • Revenue Next Year
  • SLNO N/A
  • SWI $4.51
  • P/E Ratio
  • SLNO N/A
  • SWI $28.80
  • Revenue Growth
  • SLNO N/A
  • SWI 5.03
  • 52 Week Low
  • SLNO $36.61
  • SWI $10.14
  • 52 Week High
  • SLNO $73.97
  • SWI $18.55
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 84.44
  • SWI 75.63
  • Support Level
  • SLNO $48.29
  • SWI $18.39
  • Resistance Level
  • SLNO $51.88
  • SWI $18.44
  • Average True Range (ATR)
  • SLNO 3.03
  • SWI 0.05
  • MACD
  • SLNO 2.32
  • SWI -0.09
  • Stochastic Oscillator
  • SLNO 93.61
  • SWI 83.33

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About SWI SolarWinds Corporation

SolarWinds Corp is a provider of information technology (IT), and management software. Company offers full-stack observability solutions. The company's business is focused on building products that enable technology professionals and leaders to securely monitor and manage the performance of their IT environments, whether on-premises, in the cloud or in hybrid deployments. The products offered are designed to monitor and manage networks, systems, databases and applications across on-premises, multi-cloud and hybrid IT environments without the need for customization or professional services.

Share on Social Networks: